ASM of the hip joint is a reliable early biomarker of radiographic OA severity, which can improve the ability to identify patients at higher risk of rapid progression and poor outcome even when KLG and clinical risk factors are taken into account.
Rheumatology (Oxford, England)
Bone and Musculoskeletal Research Programme, Aberdeen, UK. r.j.barr [at] abdn.ac.uk
Rheumatology (Oxford). 2012 Mar;51(3):562-70
© Galenicom 1999-2013